Idiopathic Anaphylaxis

Journal of Allergy and Clinical Immunology: In Practice

Volumn 2, Issue 3, 2014, Pages 243-250

  Greenberger, Paul A ^a   Lieberman, Phillip ^b  

^a NORTHWESTERN UNIVERSITY   (United States)

^b UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

Anaphylaxis; Galactose alpha 1,3 galactose; Idiopathic anaphylaxis; Mast cell activating disorder; Mast cell activating syndrome

Indexed keywords

ADRENERGIC RECEPTOR STIMULATING AGENT; CETIRIZINE; HISTAMINE; HISTAMINE H1 RECEPTOR ANTAGONIST; KETOTIFEN; OMALIZUMAB; PREDNISONE; PROSTAGLANDIN D2; SALBUTAMOL; TRYPTASE;

ANAPHYLAXIS; CELL ACTIVATION; CLINICAL ASSESSMENT; CRITERION VARIABLE; DIFFERENTIAL DIAGNOSIS; HUMAN; IDIOPATHIC DISEASE; IMMUNE FUNCTION TEST; INCIDENCE; MAST CELL; PATHOGENESIS; PHYSICAL EXAMINATION; QUALITY OF LIFE; REVIEW; SYSTEMIC MASTOCYTOSIS; TREATMENT PLANNING; FEMALE; IMMUNOLOGY; MALE;

ANAPHYLAXIS; FEMALE; HISTAMINE H1 ANTAGONISTS; HUMANS; MALE; SYMPATHOMIMETICS;

EID: 84899964976     PISSN: 22132198     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaip.2014.02.012     Document Type: Review

References (105)

1. Bacal E., Patterson R., Zeiss C.R. Evaluation of severe (anaphylactic) reactions. Clin Allergy 1978, 8:295-304.
2. Lieberman P., Taylor W.W. Recurrent idiopathic anaphylaxis. Arch Intern Med 1979, 139:1032-1034.
3. Blatman K.H., Ditto A.M. Idiopathic anaphylaxis. Allergy Asthma Proc 2012, 33:S84-S87.
4. Sale S.R., Greenberger P.A., Patterson R. Idiopathic anaphylactoid reactions. A clinical summary. JAMA 1981, 246:2336-2339.
5. Sheffer A.L. Unraveling the mystery of idiopathic anaphylaxis. N Engl J Med 1984, 311:1248-1249.
6. Wiggins C.A., Dykewicz M.S., Patterson R. Idiopathic anaphylaxis: a review. Ann Allergy 1989, 62:1-4.
7. Wong S., Dykewicz M.S., Patterson R. Idiopathic anaphylaxis. A clinical summary of 175 patients. Arch Intern Med 1990, 150:1323-1328.
8. Wiggins C.A., Dykewicz M.S., Patterson R. Idiopathic anaphylaxis: classification, evaluation, and treatment of 123 patients. J Allergy Clin Immunol 1988, 82:849-855.
9. Wong S., Greenberger P.A., Patterson R. Nearly fatal idiopathic anaphylaxis reaction resulting in cardiovascular collapse and myocardial infarction. Chest 1990, 98:501-503.
10. Stoloff R.S., Orfan N., Greenberger P.A., Grammer L.C., Harris K.E., Patterson R. Malignant idiopathic anaphylaxis: three additional cases and extended evaluation. Ann Allergy 1992, 69:37-42.
11. Kemp S.F., Lockey R.F., Wolf B.L., Lieberman P. Anaphylaxis: a review of 266 cases. Arch Intern Med 1995, 155:1749-1754.
12. Stoloff R., Adams S.L., Orfan N., Harris K.E., Greenberger P.A., Patterson R. Emergency medical recognition and management of idiopathic anaphylaxis. J Emerg Med 1992, 10:693-698.
13. Stoloff R., Patterson R., Harris K.E., Greenberger P.A. Idiopathic anaphylaxis. Allergy Proc 1993, 14:135-136.
14. Patterson R., Lieberman P. Idiopathic anaphylaxis: a purely internal reaction. Hosp Pract (1995) 1996, 31:47-51. 55-8, 64.
15. Krasnick J., Patterson R., Harris K.E. Idiopathic anaphylaxis: long-term follow-up, cost, and outlook. Allergy 1996, 51:724-731.
16. Patterson R., Hogan M.B., Yarnold P.R., Harris K.E. Idiopathic anaphylaxis. An attempt to estimate the incidence in the United States. Arch Intern Med 1995, 155:869-871.
17. Ditto A.M., Harris K.E., Krasnick J., Miller M.A., Patterson R. Idiopathic anaphylaxis: a series of 335 cases. Ann Allergy Asthma Immunol 1996, 77:285-291.
18. Patterson R., Clayton D.E., Booth B.H., Greenberger P.A., Grammer L.C., Harris K.E. Fatal and near fatal idiopathic anaphylaxis. Allergy Proc 1995, 16:103-108.
19. Mazur N., Patterson R., Perlman D. A case of idiopathic anaphylaxis associated with respiratory infections. Ann Allergy Asthma Immunol 1997, 79:546-548.
20. Krasnick J., Patterson R., Meyers G.L. A fatality from idiopathic anaphylaxis. Ann Allergy Asthma Immunol 1996, 76:376-378.
21. Ditto A.M., Krasnick J., Greenberger P.A., Kelly K.J., McGrath K., Patterson R. Pediatric idiopathic anaphylaxis: experience with 22 patients. J Allergy Clin Immunol 1997, 100:320-326.
22. Hogan M.B., Kelly M.A., Wilson N.W. Idiopathic anaphylaxis in children. Ann Allergy Asthma Immunol 1998, 81:140-142.
23. Patterson R., Harris K.E. Idiopathic anaphylaxis. Allergy Asthma Proc 1999, 20:311-315.
24. Mastrovich J.D., Patterson R., Davison R., Harris K.E. Using test dose challenges to restore essential therapy in patients with idiopathic anaphylaxis and pharmacophobia: report of a patient with idiopathic anaphylaxis and statin phobia. Allergy Asthma Proc 2001, 22:303-309.
25. Lenchner K.I., Ditto A.M. Idiopathic anaphylaxis. Allergy Asthma Proc 2004, 25:S54-S56.
26. Webb L.M., Lieberman P. Anaphylaxis: a review of 601 cases. Ann Allergy Asthma Immunol 2006, 97:39-43.
27. Greenberger P.A. Idiopathic anaphylaxis. Immunol Allergy Clin North Am 2007, 27:273-293.
28. Lenchner K., Grammer L.C. A current review of idiopathic anaphylaxis. Curr Opin Allergy Clin Immunol 2003, 3:305-311.
29. Tejedor Alonso M.A., Sastre D.J., Sanchez-Hernandez J.J., Perez Frances C., de la Hoz Caballer B. Idiopathic anaphylaxis: a descriptive study of 81 patients in Spain. Ann Allergy Asthma Immunol 2002, 88:313-318.
30. Olalde S.S., Fernandez Vieira L., Rodriguez Rodriguez J. Idiopathic anaphylaxis: presentation of 4 cases. Rev Clin Esp 1989, 184:305-306.
31. Moneret-Vautrin D.A. Idiopathic anaphylaxis. Eur Ann Allergy Clin Immunol 2004, 36:13-19.
32. Moneret-Vautrin D.A., Gay G. The so-called "idiopathic" anaphylaxis: allergic and pseudo-allergic reactions. Allerg Immunol (Paris) 1991, 23:89-93.
33. Bourke J., Finucane J., O'Loughlin S. Idiopathic anaphylaxis. Ir Med J 1997, 90:62.
34. Ring J., Darsow U. Idiopathic anaphylaxis. Curr Allergy Asthma Rep 2002, 2:40-45.
35. Geller M., Geller P. Malignant idiopathic anaphylaxis does exist in Brazil. Ann Allergy Asthma Immunol 2002, 88:645.
36. Tanus T., Mines D., Atkins P.C., Levinson A.L. Serum tryptase in idiopathic anaphylaxis: a case report and review of the literature. Ann Emerg Med 1994, 24:104-107.
37. Stricker W.E., Anorve-Lopez E., Reed C.E. Food skin testing in patients with idiopathic anaphylaxis. J Allergy Clin Immunol 1986, 77:516-519.
38. Sanmugam G., Schwartz L.B., Khan D.A. Prolonged elevation of serum tryptase in idiopathic anaphylaxis. J Allergy Clin Immunol 2006, 117:950-951.
39. Choy A.C., Patterson R., Patterson D.R., Grammer L.C., Greenberger P.A., McGrath K., et al. Undifferentiated somatoform idiopathic anaphylaxis: nonorganic symptoms mimicking idiopathic anaphylaxis. J Allergy Clin Immunol 1995, 96:893-900.
40. Hendrix S., Sale S., Zeiss C.R., Utley J., Patterson R. Factitious Hymenoptera allergic emergency: a report of a new variant of Munchausen's syndrome. J Allergy Clin Immunol 1981, 67:8-13.
41. Patterson R., Dykewicz M.S., Grammer L.C., Greenberger P.A., Lawrence I.D., Walker C.W., et al. Classification of immediate-type, life-threatening or pseudoallergic reactions. Chest 1990, 98:257-259.
42. Broom B.C., Fitzharris P. Life-threatening inhalant allergy: typical anaphylaxis induced by inhalational allergen challenge in patients with idiopathic recurrent anaphylaxis. Clin Allergy 1983, 13:169-179.
43. Greenberger P.A. Life-threatening idiopathic anaphylaxis associated with hyperimmunoglobulinemia E. Am J Med 1984, 76:553-556.
44. Saunders R.L., Halpern G.M., Gershwin M.E. Odor-associated idiopathic anaphylaxis. A case report. Allergol Immunopathol (Madr) 1995, 23:35-37.
45. Silva R., Gomes E., Cunha L., Falcao H. Anaphylaxis in children: a nine years retrospective study (2001-2009). Allergol et immunopathol (Madr) 2012, 40:31-36.
46. Patterson R., Tripathi A., Saltoun C., Harris K.E. Idiopathic anaphylaxis: variants as diagnostic and therapeutic problems. Allergy Asthma Proc 2000, 21:141-144.
47. Patterson R. Idiopathic anaphylaxis. The evolution of a disease. Clin Rev Allergy Immunol 1999, 17:425-428.
48. Sanchez I., Quinones D., Rodriguez F., Fernandez L., Bravo J., Garcia-Abujeta J.L., et al. Erroneous diagnosis of idiopathic anaphylaxis. Allergy 1999, 54:648-649.
49. Stoevesandt J., Grundmeier N., Trautmann A. Gastroesophageal Hymenoptera stings add to causes of idiopathic anaphylaxis. Ann Allergy Asthma Immunol 2012, 108:125-126.
50. Novembre E., Cianferoni A., Bernardini R., Mugnaini L., Caffarelli C., Cavagni G., et al. Anaphylaxis in children: clinical and allergologic features. Pediatrics 1998, 101:E8.
51. Gulen T., Gottberg L., Dahlen B., Nilsson G., Hagglund H. Systemic mastocytosis. Underestimated condition in patients with idiopathic anaphylaxis. Lakartidningen 2012, 109:474-477.
52. Bobolea I., Guillen D., Barranco P., Alvarez-Escola C., Quirce S. Recurrent anaphylactic reactions: an uncommon debut of lymphocytic hypophysitis. Int Arch Allergy Immunol 2012, 159:103-106.
53. Picard M., Giavina-Bianchi P., Mezzano V., Castells M. Expanding spectrum of mast cell activation disorders: monoclonal and idiopathic mast cell activation syndromes. Clin Ther 2013, 35:548-562.
54. Stallings A.P., Platts-Mills T.A.E., Oliveira W.M., Workman L., James H.R., et al. Galactose-α-1,3-galactose and delayed anaphylaxis, angioedema, and urticarial in children. Pediatrics 2013, 1341:e1545-e1552.
55. Reed J., Yedulapuram M., Lieberman P., Fitzpatrick E. Differences in cytokine production between idiopathic anaphylaxis (IA) subjects and controls. J Allergy Clin Immunol 2006, 117:S305.
56. Sonin L., Patterson R. Metabisulfite challenge in patients with idiopathic anaphylaxis. J Allergy Clin Immunol 1985, 75:67-69.
57. Slater J.E., Kaliner M. Effects of sex hormones on basophil histamine release in recurrent idiopathic anaphylaxis. J Allergy Clin Immunol 1987, 80:285-290.
58. Orhan F., Canitez Y., Bakirtas A., Yilmaz O., Boz A.B., Can D., et al. Anaphylaxis in Turkish children: a multi-centre, retrospective, case study. Clin Exp Allergy 2011, 41:1767-1776.
59. Slater J.E., Raphael G., Cutler G.B., Loriaux D.L., Meggs W.J., Kaliner M. Recurrent anaphylaxis in menstruating women: treatment with a luteinizing hormone-releasing hormone agonist: a preliminary report. Obstet Gynecol 1987, 70:542-546.
60. Patterson R., Greenberger P.A., Grammer L.C., Zeiss C.R., Harris K.E., Shaughnessy M.A. Idiopathic anaphylaxis (IA): suggested theories relative to the pathogenesis and response to therapy. Allergy Proc 1993, 14:365-367.
61. Grammer L.C., Shaughnessy M.A., Harris K.E., Goolsby C.L. Lymphocyte subsets and activation markers in patients with acute episodes of idiopathic anaphylaxis. Ann Allergy Asthma Immunol 2000, 85:368-371.
62. Tejedor Alonso M.A., Sastre Dominguez J., Sanchez-Hernandez J.J., Perez Frances C., de la Caballer H. Clinical and functional differences among patients with idiopathic anaphylaxis. J Investig Allergol Clin Immunol 2004, 14:177-186.
63. Tedeschi A., Lorini M., Sull C., Cugno M. Detection of serum histamine-releasing factors in a patient with idiopathic anaphylaxis and multiple drug allergy syndrome. J Investig Allergol Clin Immunol 2007, 17:122-125.
64. Akin C., Scott L.M., Kocabas C.N., Kushnir-Sukhov N., Brittain E., Noel P., et al. Demonstration of an aberrant mast-cell population with clonal markers in a subset of patients with "idiopathic" anaphylaxis. Blood 2007, 110:2331-2333.
65. Commins S.P., Platts-Mills T.A. Anaphylaxis syndromes related to a new mammalian cross-reactive carbohydrate determinant. J Allergy Clin Immunol 2009, 124:652-657.
66. Patterson R., Greenberger P.A., Orfan N.A., Stoloff R.S. Idiopathic anaphylaxis: diagnostic variants and the problem of nonorganic disease. Allergy Proc 1992, 13:133-137.
67. Orfan N.A., Stoloff R.S., Harris K.E., Patterson R. Idiopathic anaphylaxis: total experience with 225 patients. Allergy Proc 1992, 13:35-43.
68. Boxer M.B., Greenberger P.A., Patterson R. The impact of prednisone in life-threatening idiopathic anaphylaxis: reduction in acute episodes and medical costs. Ann Allergy 1989, 62:201-204.
69. Wiggins C.A., Dykewicz M.S., Patterson R. Corticosteroid-dependent idiopathic anaphylaxis: a report of five cases. J Allergy Clin Immunol 1989, 84:311-315.
70. Mehl A., Wahn V., Niggeman B. Anaphylactic reactions in children: a questionnaire-based survey in Germany. Allergy 2005, 60:1440-1445.
71. Dykewicz M.S., Wong S.S., Patterson R., Harris K.E. Evaluation of ketotifen in corticosteroid-dependent idiopathic anaphylaxis. Ann Allergy 1990, 65:406-410.
72. Wong S., Yarnold P.R., Yango C., Patterson R., Harris K.E. Outcome of prophylactic therapy for idiopathic anaphylaxis. Ann Intern Med 1991, 114:133-136.
73. Wong S., Patterson R., Harris K.E., Dykewicz M.S. Efficacy of ketotifen in corticosteroid-dependent idiopathic anaphylaxis. Ann Allergy 1991, 67:359-364.
74. Patterson R., Fitzsimons E.J., Choy A.C., Harris K.E. Malignant and corticosteroid-dependent idiopathic anaphylaxis: successful responses to ketotifen. Ann Allergy Asthma Immunol 1997, 79:138-144.
75. Patterson R., Greenberger P.A. Problems in the management of idiopathic anaphylaxis. Allergy Asthma Proc 2001, 22:295-296.
76. Jones J.D., Marney S.R., Fahrenholz J.M. Idiopathic anaphylaxis successfully treated with omalizumab. Ann Allergy Asthma Immunol 2008, 101:550-551.
77. Warrier P., Casale T.B. Omalizumab in idiopathic anaphylaxis. Ann Allergy Asthma Immunol 2009, 102:257-258.
78. Demirturk M., Gelincik A., Colakoglu B., Dal M., Büyüköztürk S. Promising option in the prevention of idiopathic anaphylaxis: omalizumab. J Dermatol 2012, 39:552-554.
79. Boxer M., Greenberger P.A., Patterson R. Clinical summary and course of idiopathic anaphylaxis in 73 patients. Arch Intern Med 1987, 147:269-272.
80. Valent P., Akin C., Arock M., Brockow K., Butterfield J.H., Carter M.C., et al. Definitions, criteria and global classifications of mast cell disorders with special reference to mast cell activation syndromes: a consensus proposal. Int Arch Allergy Immunol 2012, 157:215-225.
81. Khan D.A., Yocum M.W. Clinical course of idiopathic anaphylaxis. Ann Allergy 1994, 73:370-374.
82. Horny H.P., Metcalfe D.D., Bennett J.M., Bain B.J., Akin C., Escribano L., et al. Mastocytosis. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues 2008, 54-63. IARC Press, Lyon, France. 4th ed. S.H. Swerdlow, E. Campo, N.L. Harris, E.S. Jaffe, S.A. Pileri, H. Stein (Eds.).
83. Bonadonna P., Perbellini O., Passalacqua G., Caruso B., Colarossi S., Dal Fior D., et al. Systemic reactions after Hymenoptera sting and raised serum tryptase strongly suggest clonal mast cells disorders. Clonal mast cell disorders in patients with systemic reactions to Hymenoptera stings and increased serum tryptase levels. J Allergy Clin Immunol 2009, 123:680-686.
84. Ortolani C., Ispano M., Pastorello E.A., Ansaloni R., Magri G.C. Comparison of results of skin prick tests (with fresh foods and commercial food extracts) and RAST in 100 patients with oral allergy syndrome. J Allergy Clin Immunol 1989, 83:683-690.
85. Jensen B.M., Akin C., Gilfillan A.M. Pharmacological targeting of the KIT growth factor receptor: a therapeutic consideration for mast cell disorders. Br J Pharmacol 2008, 154:1572-1582.
86. Agarwala M.K., George R., Mathews V., Balasubramanian P., Thomas M., Nair S. Role of imatinib in the treatment of pediatric onset indolent systemic mastocytosis: a case report. J Dermatolog Treat 2013, 24:481-483.
87. Geha R.S., Beiser A., Ren C., Patterson R., Greenberger P.A., Grammer L.C., et al. Multicenter, double-blind, placebo-controlled, multiple-challenge evaluation of reported reactions to monosodium glutamate. J Allergy Clin Immunol 2000, 106:973-980.
88. Geha R., Buckley C.E., Greenberger P., Patterson R., Polmar S., Saxon A., et al. Aspartame is no more likely than placebo to cause urticaria/angioedema: results of a multicenter, randomized, double-blind, placebo-controlled, crossover study. J Allergy Clin Immunol 1993, 92:513-520.
89. Greenberger P.A. Idiopathic anaphylaxis. Immunol Allergy Clin North Am 1992, 12:571-583.
90. Greenberger P.A., Smith L.J., Patterson R., Krell R.D., Roberts M., Harris K.E., et al. Comparison of cutaneous and bronchial reactivity to leukotriene D4 in humans. J Lab Clin Med 1986, 108:70-75.
91. Garriga M.M., Friedman M.M., Metcalfe D.D. A survey of the number and distribution of mast cells in the skin of patients with mast cell disorders. J Allergy Clin Immunol 1988, 82:425-432.
92. Ditto A.M., Grammer L.C., Kern R.C. Direct laryngoscopy with provocation: a useful method to distinguish acute laryngeal edema from nonorganic disease. Ann Allergy Asthma Immunol 1995, 75:25-28.
93. Masood D., Brown J.E., Patterson R., Greenberger P.A., Berkowitz L. Recurrent anaphylaxis due to unrecognized latex hypersensitivity in two healthcare professionals. Ann Allergy Asthma Immunol 1995, 74:311-313.
94. Vadas P., Gold M., Perelmann M., Liss G.M., Lack G., Blyth T., et al. Platelet-activating factor, PAF acetylhydrolase, and severe anaphylaxis. N Engl J Med 2008, 358:28-35.
95. Vadas P., Perelman B., Liss G. Platelet-activating factor, histamine, and tryptase levels in human anaphylaxis. J Allergy Clin Immunol 2013, 131:144-149.
96. Becker K., Southwick K., Reardon J., Berg R., MacCormack J.N. Histamine poisoning associated with eating tuna burgers. JAMA 2001, 285:1327-1330.
97. Sánchez-Borges M., Suárez Chacón R., Capriles-Hulett A., Caballero-Fonseca F., Fernández-Caldas E. Anaphylaxis from ingestion of mites: pancake anaphylaxis. J Allergy Clin Immunol 2013, 131:31-35.
98. Roberts L.J., Bloomgarden Z.T., Marney S.R., Rabin D., Oates J.A. Histamine release from a gastric carcinoid: provocation by pentagastrin and inhibition by somatostatin. Gastroenterology 1983, 84:272-275.
99. Smith C.H., Atkinson B., Morris R.W., Hayes N., Foreman J.C., Lee T.H. Cutaneous responses to vasoactive intestinal polypeptide in chronic idiopathic urticaria. Lancet 1992, 339:91-93.
100. Erem C., Kocak M., Ersoz H.O., Ersoz S., Yucel Y. Epinephrine-secreting cystic pheochromocytoma presenting with an incidental adrenal mass. Endocrine 2005, 38:225-230.
101. Peroni D.G., Piacentini G.L., Piazza M., Cametti E., Boner A.L. Combined cetirizine-montelukast preventive treatment for food-dependent exercise-induced anaphylaxis. Ann Allergy Asthma Immunol 2010, 104:272-273.
102. Menendez R., Venzor J., Ortiz G. Failure of zafirlukast to prevent ibuprofen-induced anaphylaxis. Ann Allergy Asthma Immunol 1998, 80:225-226.
103. Bauer C.S., Vadas P., Kelly K.J. Methylene blue for the treatment of refractory anaphylaxis without hypotension. Am J Emerg Med 2013, 31:264.e3-264.e5.
104. Senthilkumaran S., Menezes R.G., Nath J.M., Thirumalaikolundusubramanian P. Methylene blue for refractory anaphylaxis: is it a magic bullet?. Am J Emerg Med 2013, 31:1140.
105. Valent P., Horny H.P., Escribano L., Longley B.J., Li C.Y., Schwartz L.B., et al. Diagnostic criteria and classification of mastocytosis: a consensus proposal. Leuk Res 2001, 25:603-625.